164 related articles for article (PubMed ID: 32045884)
21. Cervical Lymph Node Metastases of Papillary Thyroid Carcinoma, in the Central and Lateral Compartments, in Children and Adolescents: Predictive Factors.
Spinelli C; Tognetti F; Strambi S; Morganti R; Massimino M; Collini P
World J Surg; 2018 Aug; 42(8):2444-2453. PubMed ID: 29383423
[TBL] [Abstract][Full Text] [Related]
22. The binary presence or absence of lymph node metastasis or extrathyroidal extension is not associated with survival in papillary thyroid cancers: Implications for staging systems.
Zhang HS; Lee EK; Jung YS; Nam BH; Park B
Cancer Epidemiol; 2019 Dec; 63():101589. PubMed ID: 31494519
[TBL] [Abstract][Full Text] [Related]
23. CLDN10 is Associated with Papillary Thyroid Cancer Progression.
Zhou Y; Xiang J; Bhandari A; Guan Y; Xia E; Zhou X; Wang Y; Wang O
J Cancer; 2018; 9(24):4712-4717. PubMed ID: 30588256
[TBL] [Abstract][Full Text] [Related]
24. Development of a prognostic index based on an immunogenomic landscape analysis of papillary thyroid cancer.
Lin P; Guo YN; Shi L; Li XJ; Yang H; He Y; Li Q; Dang YW; Wei KL; Chen G
Aging (Albany NY); 2019 Jan; 11(2):480-500. PubMed ID: 30661062
[TBL] [Abstract][Full Text] [Related]
25. LIMD2 Is Overexpressed in BRAF V600E-Positive Papillary Thyroid Carcinomas and Matched Lymph Node Metastases.
Pinheiro Dos Santos MJC; Bastos AU; da Costa VR; Delcelo R; Lindsey SC; Colozza-Gama GA; Peng H; Rauscher FJ; Oler G; Cerutti JM
Endocr Pathol; 2018 Sep; 29(3):222-230. PubMed ID: 29560564
[TBL] [Abstract][Full Text] [Related]
26. Beclin 1 is highly expressed in papillary thyroid carcinoma and correlates with lymph node metastasis.
Li X; Xu H; Ma H
Acta Chir Belg; 2013; 113(3):175-81. PubMed ID: 24941712
[TBL] [Abstract][Full Text] [Related]
27. Preoperative serum VEGF-C but not VEGF-A level is correlated with lateral neck metastasis in papillary thyroid carcinoma.
Jang JY; Kim DS; Park HY; Shin SC; Cha W; Lee JC; Wang SG; Lee BJ
Head Neck; 2019 Aug; 41(8):2602-2609. PubMed ID: 30843635
[TBL] [Abstract][Full Text] [Related]
28. High expression and localization of β-catenin and epidermal growth factor receptor identify high risk papillary thyroid carcinoma patients.
Išić Denčić T; Bartolome A; Šelemetjev S; Đorić I; Tatić S; Živaljević V; Cvejić D
Exp Mol Pathol; 2018 Oct; 105(2):181-189. PubMed ID: 30077672
[TBL] [Abstract][Full Text] [Related]
29. [Risk factors analyses for lateral neck lymph node metastasis in papillary thyroid carcinoma].
Qi ZJ; Liu LF; Cheng L; Han X; Wang T; Li F; Lu C; Zhang AB
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Jul; 33(7):603-606. PubMed ID: 31327195
[No Abstract] [Full Text] [Related]
30. MicroRNAs and Lymph Node Metastasis in Papillary Thyroid Cancers.
Mutalib NS; Yusof AM; Mokhtar NM; Harun R; Muhammad R; Jamal R
Asian Pac J Cancer Prev; 2016; 17(1):25-35. PubMed ID: 26838219
[TBL] [Abstract][Full Text] [Related]
31. Transcriptome Analyses Identify a Metabolic Gene Signature Indicative of Dedifferentiation of Papillary Thyroid Cancer.
Ma B; Jiang H; Wen D; Hu J; Han L; Liu W; Xu W; Shi X; Wei W; Liao T; Wang Y; Lu Z; Wang Y; Ji Q
J Clin Endocrinol Metab; 2019 Sep; 104(9):3713-3725. PubMed ID: 30942873
[TBL] [Abstract][Full Text] [Related]
32. Relationship between expression of vascular endothelial growth factor and cervical lymph node metastasis in papillary thyroid cancer: A meta-analysis.
Huang XQ; He WS; Zhang HQ; Yang R; Huang T
J Huazhong Univ Sci Technolog Med Sci; 2017 Oct; 37(5):661-666. PubMed ID: 29058277
[TBL] [Abstract][Full Text] [Related]
33. Markers of immune activation: novel biomarkers to predict the early-warning indicator of patients with papillary thyroid carcinoma.
Lu H; Zhang L; Dai Y; Ruan Y; Cao X; Cai X; Ruan S; Chen Q
Diagn Pathol; 2020 Feb; 15(1):16. PubMed ID: 32050977
[TBL] [Abstract][Full Text] [Related]
34. The utility of lymph node mapping sonogram and thyroglobulin surveillance in post thyroidectomy papillary thyroid cancer patients.
Miah CF; Zaman JA; Simon M; Davidov T; Trooskin SZ
Surgery; 2014 Dec; 156(6):1491-6; discussion 1496-7. PubMed ID: 25456939
[TBL] [Abstract][Full Text] [Related]
35. A meta-analysis evaluating the relationship between B-type Raf kinase mutation and cervical lymphatic metastasis in papillary thyroid cancer.
Ma H; Wang R; Fang J; Zhong Q; Chen X; Hou L; Feng L; Chen X; Huang Z; Zhao H
Medicine (Baltimore); 2020 Jan; 99(5):e18917. PubMed ID: 32000400
[TBL] [Abstract][Full Text] [Related]
36. Expression profiling and bioinformatics analysis of serum exosomal circular RNAs in lymph node metastasis of papillary thyroid carcinoma.
Peng H; Zhu Z; Xing J; Xu Q; Man C; Wang S; Liu Y; Zhang Z
J Biomed Res; 2024 May; ():1-15. PubMed ID: 38812291
[TBL] [Abstract][Full Text] [Related]
37. HIF1A overexpression predicts the high lymph node metastasis risk and indicates a poor prognosis in papillary thyroid cancer.
Zhao YX; Yang Z; Ma LB; Wang F; Wang Y; Xiang C
Heliyon; 2023 Mar; 9(3):e14714. PubMed ID: 36994412
[TBL] [Abstract][Full Text] [Related]
38. [Clinicopathological factors in risk prediction of lymph node metastasis in papillary thyroid carcinoma].
Yue C; Zhang Y; Xing L; Zhao Y; Chen J; Jin Y; Liu H
Zhonghua Yi Xue Za Zhi; 2014 Dec; 94(46):3637-41. PubMed ID: 25622954
[TBL] [Abstract][Full Text] [Related]
39. [Expression of microRNA-221 and IL-17 in papillary thyroid carcinoma and correlation with clinicopathologic features].
Jiang XL; Zhang H; Chen YL; Peng L
Zhonghua Bing Li Xue Za Zhi; 2017 Mar; 46(3):160-165. PubMed ID: 28297755
[No Abstract] [Full Text] [Related]
40. Overexpression of epidermal growth factor receptor and its downstream effector, focal adhesion kinase, correlates with papillary thyroid carcinoma progression.
Šelemetjev S; Bartolome A; Išić Denčić T; Đorić I; Paunović I; Tatić S; Cvejić D
Int J Exp Pathol; 2018 Apr; 99(2):87-94. PubMed ID: 29665129
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
